GP
Gross Paul Edward Autre
Other M
US US · SEC (Form 4)
Discover the full record of transactions filed by Gross Paul Edward, Autre. Director active across 1 companies, notably Clovis Oncology, Inc.. In total, 17 disclosures have been recorded. Regulator: SEC (Form 4). All data is openly available.
Declarations 17 total
5,062 shares
Common Stock
SEC:0000899243-22-020945:0 · 1 Jun 2022
5,623 shares
Common Stock
SEC:0000899243-22-016293:0 · 1 May 2022
563 shares
Common Stock
SEC:0000899243-22-009058:0 · 1 Mar 2022
5,625 shares
Common Stock
SEC:0000899243-22-004569 · 1 Feb 2022
5,625 shares
Common Stock
SEC:0000899243-22-004569:0 · 1 Feb 2022
562 shares
Common Stock
SEC:0000899243-21-046762 · 1 Dec 2021
562 shares
Common Stock
SEC:0000899243-21-046762:0 · 1 Dec 2021
5,623 shares
Common Stock
SEC:0000899243-21-042701 · 1 Nov 2021
5,623 shares
Common Stock
SEC:0000899243-21-042701:0 · 1 Nov 2021
563 shares
Common Stock
SEC:0000899243-21-035115 · 1 Sept 2021
563 shares
Common Stock
SEC:0000899243-21-035115:0 · 1 Sept 2021
5,624 shares
Common Stock
SEC:0000899243-21-031438 · 1 Aug 2021
5,624 shares
Common Stock
SEC:0000899243-21-031438:0 · 1 Aug 2021
562 shares
Common Stock
SEC:0000899243-21-021859 · 1 Jun 2021
562 shares
Common Stock
SEC:0000899243-21-021859:0 · 1 Jun 2021
2,556 shares
Common Stock
SEC:0000899243-21-018274:0 · 1 May 2021
2,556 shares
Common Stock
SEC:0000899243-21-018274 · 1 May 2021
About Gross Paul Edward Paul Edward Gross is an executive at Clovis Oncology, Inc.